Review of the 2nd day of the II Scientific and Practical Conference in a hybrid format “Achievements, problems and prospects in hematology”. Treatment and diagnosis of patients wit... Tekijä V. A. Shuvaev

Hae kokoteksti

How we treat polycythemia vera Tekijä V. A. Shuvaev, I. S. Martynkevich

Hae kokoteksti

All we know about polycythemia vera: literature review and own experience Tekijä K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Hae kokoteksti

Dasatinib: ten years of clinical practice worldwide Tekijä K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Hae kokoteksti

Primary myelofibrosis: own experience and news from diagnostic and treatment Tekijä K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Hae kokoteksti

Primary myelofibrosis: own experience and news from diagnostic and treatment Tekijä K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Hae kokoteksti

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission Tekijä V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Hae kokoteksti

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission Tekijä V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Hae kokoteksti

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults Tekijä E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

Hae kokoteksti

Clinical Case of Posterior Reversible Encephalopathy Syndrome in a Female Patient Undergoing Surgery for Rectal Cancer Tekijä M. M. Geraskinа, A. B. Galitsynа, V. A. Shuvaev, S. S. Gosteva

Hae kokoteksti

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma Tekijä S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Hae kokoteksti

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma Tekijä S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Hae kokoteksti

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis Tekijä M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Hae kokoteksti

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients Tekijä V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Hae kokoteksti

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients Tekijä V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Hae kokoteksti

Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia Tekijä D. V. Kustova, E. V. Motyko, A. N. Kirienko, T. N. Gert, I. V. Leppyanen, M. P. Bakay, E. V. Efremova, E. V. Morozova, E. G. Lomaia, V. A. Shuvaev, S. V. Sidorkevich, I. S. Martynkevich

Hae kokoteksti

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA Tekijä A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov

Hae kokoteksti

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients Tekijä S. V. Voloshin, A. D. Garifullin, A. A. Kuzyaeva, N. N. Sinitsina, N. N. Alekseeva, A. V. Schmidt, S. Y. Linnikov, V. A. Shuvaev, A. Y. Kuvshinov, N. A. Potikhonova, A. V. Seltser, V. A. Balashova, Z. V. Chubukina, A. N. Bogdanov, S. V. Sidorkevich

Hae kokoteksti

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy Tekijä A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko

Hae kokoteksti